Eunice Kennedy Shriver NICHD Cooperative Multicenter Neonatal Research Network
尤尼斯·肯尼迪·施赖弗 (Eunice Kennedy Shriver) NICHD 合作多中心新生儿研究网络
基本信息
- 批准号:8643279
- 负责人:
- 金额:$ 29.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-05-01 至 2016-03-31
- 项目状态:已结题
- 来源:
- 关键词:Active SitesApolipoprotein EAutologousAwardBiomedical EngineeringBlood CellsBronchopulmonary DysplasiaCandidate Disease GeneCandidiasisCaringCatalogingCatalogsChildhoodClinicClinical ResearchClinical SciencesClinical TrialsClinical Trials NetworkClinical and Translational Science AwardsCollaborationsCommitCommunicable DiseasesCost SharingDNA LibraryDatabasesDevelopmentDiagnosisDisciplineEarly DiagnosisEnrollmentExtremely Low Birth Weight InfantFacultyFosteringFundingGeneric DrugsGenomicsGenotypeGoalsGrantHealthHuman ResourcesInfantInstructionLeadLinkLow Birth Weight InfantManuscriptsMarshalMedicalMentorsMorbidity - disease rateMulticenter Neonatal Research NetworkNational Institute of Child Health and Human DevelopmentNeonatalNeonatal ScreeningNeonatologyNewborn InfantNorth CarolinaOutcomePatientsPerinatalPilot ProjectsPopulation StudyPregnancyPreparationPricePrincipal InvestigatorProtocols documentationPublicationsReportingResearchResearch InstituteResearch PersonnelResourcesSamplingScientistSiteSocietiesTestingThe science of MycologyTherapeuticTrainingTranslational ResearchUmbilical Cord BloodUnited States National Institutes of HealthUniversitiesWorkcareer developmentexperiencefollow-upgenetic epidemiologygenome wide association studyimprovedinnovationinterdisciplinary approachmedical schoolsmultidisciplinarynatural hypothermianeonatal hypoxic-ischemic brain injuryneonatenew technologypatient populationpublic health relevancesoundsymposium
项目摘要
DESCRIPTION (provided by applicant): The Duke University School of Medicine, Division of Neonatology enthusiastically submits this renewal application for a third consecutive cycle of participation in the Eunice Kennedy Shriver NlCHD-sponsored Cooperative Multicenter Neonatal Research Network (NRN). The NRN's purpose is to perform interventional and observational clinical studies in newborn infants, particularly those of low birth weight or gestation, with the goal of achieving improved medical and neurodevelopmental outcomes. Our aims at Duke are to: 1) prioritize and conduct approved NRN protocols while maintaining a > 90% follow-up rate; 2) foster development of trainees and collaborations with investigators from multiple disciplines to advance the care of neonates; 3) bring innovative, cutting-edge research opportunities to the NRN. In support of these aims we added the University of North Carolina at Chapel Hill (UNC) as a satellite site in January 2009. The addition of UNC doubles the study population and enhances our clinical trial expertise. We are the only current NRN site participating in all three current NRN pilot studies, and enrolled the 3'^ highest number of infants in the 2009 Generic Data Base. We maintain multidisciplinary follow-up clinics with follow-up rates for clinical trials > 90%. We participate in nine active NRN subcommittees, and lead two major Network projects that combine institutional expertise in Infectious Diseases, Medical Mycology, Biomedical Engineering, and Genetic Epidemiology, namely, Early Diagnosis of Neonatal Candidiasis and the NICHD NRN Anonymized DNA Bank. In 2010 we and investigators from 5 NRN sites are using the DNA bank to complete a genome wide scan and 7 candidate gene analyses for common morbidities of extremely low birthweight infants. We have authored or co-authored 16 NRN publications in the last cycle. We prioritize involvement of junior faculty in the NRN as attested by their concept and study applications and participation in subcommittees. At PAS in 2010 young investigators from Duke and two other NRN sites presented secondary analyses of the Candidiasis study. Duke and UNC are Clinical and Translational Science Award (CTSA) sites. CTSA directly supports our NRN work and adds further opportunity for innovation.
描述(由申请人提供):杜克大学医学院,新生儿学系热情地提交了这一续签申请,连续第三个参与Eunice Kennedy Shriver NLCHD赞助的合作合作多中心新生儿研究网络(NRN)。 NRN的目的是对新生婴儿,尤其是出生体重或妊娠的介入和观察性临床研究进行介入和观察性临床研究,以实现改善的医疗和神经发育结果。我们对杜克大学的目标是:1)优先级和执行批准的NRN协议,同时保持> 90%的随访率; 2)促进学员的发展和与来自多个学科的调查人员的合作,以推动新生儿的照顾; 3)为NRN带来创新的尖端研究机会。 为了支持这些目标,我们在2009年1月将北卡罗来纳大学的教堂山分校(UNC)添加为卫星站点。UNC的增加增加了研究人群并增强了我们的临床试验专业知识。我们是当前参与所有三项NRN试点研究的唯一当前NRN站点,并且在2009年通用数据库中招募了3'^最高婴儿。我们维持多学科的随访诊所,其临床试验的随访率> 90%。我们参加了9个活跃的NRN小组委员会,并领导了两个主要的网络项目,这些项目结合了传染病,医学真菌学,生物医学工程和遗传流行病学方面的机构专业知识,即对新生儿念珠菌病和NICHD NRN Anymined DNA Bank的早期诊断。 2010年,我们和来自5个NRN站点的研究人员正在使用DNA库来完成基因组广泛的扫描和7种候选基因分析,以分析极低的出生体重婴儿的常见病因。在上一个周期中,我们撰写或合着了16个NRN出版物。我们优先考虑初级教师参与NRN,这是由他们的概念和研究应用和参与小组委员会的参与。在2010年的PAS上,来自杜克大学的年轻研究人员和其他两个NRN站点进行了念珠菌病研究的次要分析。公爵和UNC是临床和转化科学奖(CTSA)网站。 CTSA直接支持我们的NRN工作,并增加了创新的机会。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHARLES Michael COTTEN其他文献
CHARLES Michael COTTEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHARLES Michael COTTEN', 18)}}的其他基金
Gastrin-Releasing Peptide and Bronchopulmonary Dysplasia
胃泌素释放肽与支气管肺发育不良
- 批准号:
8913762 - 财政年份:2011
- 资助金额:
$ 29.95万 - 项目类别:
Gastrin-Releasing Peptide and Bronchopulmonary Dysplasia
胃泌素释放肽与支气管肺发育不良
- 批准号:
8187308 - 财政年份:2011
- 资助金额:
$ 29.95万 - 项目类别:
Gastrin-Releasing Peptide and Bronchopulmonary Dysplasia
胃泌素释放肽与支气管肺发育不良
- 批准号:
8316372 - 财政年份:2011
- 资助金额:
$ 29.95万 - 项目类别:
Gastrin-Releasing Peptide and Bronchopulmonary Dysplasia
胃泌素释放肽与支气管肺发育不良
- 批准号:
8523962 - 财政年份:2011
- 资助金额:
$ 29.95万 - 项目类别:
Gastrin-Releasing Peptide and Bronchopulmonary Dysplasia
胃泌素释放肽与支气管肺发育不良
- 批准号:
8704990 - 财政年份:2011
- 资助金额:
$ 29.95万 - 项目类别:
Eunice Kennedy Shriver NICHD Cooperative Multicenter Neonatal Research Network
尤尼斯·肯尼迪·施赖弗 (Eunice Kennedy Shriver) NICHD 合作多中心新生儿研究网络
- 批准号:
10352224 - 财政年份:2001
- 资助金额:
$ 29.95万 - 项目类别:
Eunice Kennedy Shriver NICHD Cooperative Multicenter Neonatal Research Network
尤尼斯·肯尼迪·施赖弗 (Eunice Kennedy Shriver) NICHD 合作多中心新生儿研究网络
- 批准号:
9249619 - 财政年份:2001
- 资助金额:
$ 29.95万 - 项目类别:
Eunice Kennedy Shriver NICHD Cooperative Multicenter Neonatal Research Network
尤尼斯·肯尼迪·施赖弗 (Eunice Kennedy Shriver) NICHD 合作多中心新生儿研究网络
- 批准号:
10348104 - 财政年份:2001
- 资助金额:
$ 29.95万 - 项目类别:
Eunice Kennedy Shriver NICHD Cooperative Multicenter Neonatal Research Network
尤尼斯·肯尼迪·施赖弗 (Eunice Kennedy Shriver) NICHD 合作多中心新生儿研究网络
- 批准号:
9898411 - 财政年份:2001
- 资助金额:
$ 29.95万 - 项目类别:
相似国自然基金
载脂蛋白E模拟肽(6KApoEp)激活LRP1抑制CypA/NF-κB/MMP-9通路降低脑出血后病灶周围血脑屏障通透性
- 批准号:82260244
- 批准年份:2022
- 资助金额:32 万元
- 项目类别:地区科学基金项目
纳米脂质颗粒ApoE-rHDL靶向调控MDSCs重塑免疫微环境在胶质母细胞瘤免疫治疗中的作用与机制研究
- 批准号:81902529
- 批准年份:2019
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
载脂蛋白E对人干细胞稳态和衰老的调控作用及机制
- 批准号:81901433
- 批准年份:2019
- 资助金额:20.5 万元
- 项目类别:青年科学基金项目
基于多模态磁共振成像研究APOEε4和CLU交互作用对健康人海马的调控机制
- 批准号:81801686
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
SR蛋白在大脑脂代谢以及阿尔茨海默病病理过程中的作用机制研究
- 批准号:31871082
- 批准年份:2018
- 资助金额:59.0 万元
- 项目类别:面上项目
相似海外基金
In vivo function and tolerance to Factor VIII variants
体内功能和对因子 VIII 变体的耐受性
- 批准号:
7546518 - 财政年份:2007
- 资助金额:
$ 29.95万 - 项目类别:
In vivo function and tolerance to Factor VIII variants
体内功能和对因子 VIII 变体的耐受性
- 批准号:
7347439 - 财政年份:2007
- 资助金额:
$ 29.95万 - 项目类别:
Signaling pathway for Apolipoprotein E inhibition of innate immune
载脂蛋白 E 抑制先天免疫的信号通路
- 批准号:
19700326 - 财政年份:2007
- 资助金额:
$ 29.95万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
In vivo function and tolerance to Factor VIII variants
体内功能和对因子 VIII 变体的耐受性
- 批准号:
7736780 - 财政年份:2007
- 资助金额:
$ 29.95万 - 项目类别: